COVID-19 vaccine will be ready by year end in ‘best case scenario’: Pfizer
New York: Pfizer, which has struck a nearly $2 billion deal with the US government to deliver 100 million doses of a COVID-19 vaccine developed in collaboration with its German partner BioNTech, is hoping to seek regulatory approval for a…